Atacand Dose Ranging in Hypertensive Pediatric Subjects 1 Year to Less Than 6 Years of Age
Clinical trial NCT00244621 · COMPLETED
Trial details
- NCT number
- NCT00244621
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-11-01
- Primary completion
- 2008-08-01
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.